ShEEP Request for IVIS SPECTRUMCT, 2D and 3D Optical In Vivo Tomography System.
ShEEP Request for IVIS SPECTRUMCT, 2D and 3D Optical In Vivo Tomography System.
批准号:
9907225
负责人:
Hee-Jeong Im Sampen
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-30
关键词:
3-DimensionalAdvisory CommitteesAlcohol abuseAlzheimer&aposs DiseaseAnatomyAnimal ModelAnimalsAnxietyBasic ScienceBioluminescenceChicagoChronicClinical InvestigatorClinical Trials DesignDataData SetDegenerative polyarthritisDetectionDiabetic NeuropathiesDigital Imaging and Communications in MedicineDiseaseDoseDrug KineticsDrug toxicityEnsureEquipmentEvaluationFluorescenceFluorochromeFoundationsFundingGenerationsGoalsGrantImageImage AnalysisImage EnhancementIndustryInflammatoryInterdisciplinary StudyIntuitionLaboratoriesLongitudinal StudiesMagnetic Resonance ImagingManufacturer NameMedical centerMental DepressionMetabolic DiseasesMinorModalityModelingMolecularMotionMultiple SclerosisObesityOptical TomographyOpticsOrthopedicsPainPain ResearchParkinson DiseasePerformancePharmacodynamicsPilot ProjectsPositron-Emission TomographyProceduresResearchResearch PersonnelResearch SupportScanningServicesSheepSurfaceSystemSystems AnalysisTechnical ExpertiseTechniquesTechnologyThree-Dimensional ImageTimeTissue HarvestingTracerTrainingUnited States National Institutes of HealthUniversitiesVeteransWorkX-Ray Computed Tomographyanimal facilitybiomarker identificationcherenkov imagingcomplex biological systemsdesigndetectorexperiencegastrointestinalgerm free conditiongut microbesimaging capabilitiesimaging modalityimaging softwareimaging systemin vivoin vivo imagingin vivo imaging systemin vivo optical imaginginsightinstrumentluminescencemultidisciplinarynovel therapeuticsoptical imagingpre-clinicalpre-clinical researchprogramsradiotracerreal-time imagesreconstructionresearch and developmentscreeningsingle photon emission computed tomographytherapy developmenttomography
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
We propose to acquire an IVIS (IN VIVO IMAGING SYSTEM) SPECTRUMCT. It has multiple
functions, including 2D Bioluminescence, 3D Bioluminescence/ Fluorescence Tomography, PET,
CT and MRI functions for small and large animals, detection of in vivo Ca2+ influx that can be
useful for pain study, and drug toxicity evaluation that is critical for identifying and developing new
drugs. Presently there is no any highly sensitive tomographic optical imaging systems of this kind
available to researchers in Jesse Brown VAMC to support VA-funded studies. This instrument will
be the first IVIS SPECTRUMCT at the Jesse Brown VAMC, and will significantly accelerate data
generation for the VA-funded studies by providing sophisticated in vivo analytical capabilities that
are currently unavailable at the Jesse Brown VAMC or nearby universities. By using the new
analytical in vivo imaging capabilities, we also expect to use significantly fewer animals for our
proposed studies by eliminating time-course studies that require sacrificing animals followed by
tissue harvest. Approximately 85% of the instrument time will be utilized by these VA-funded
major users, and the remaining time will be used to support NIH-, DoD-funded or other pilot
projects. This instrument will be located in the VA Animal Facility where the VA investigators can
conduct in vivo imaging analyses without taking the animals out of the animal facility, which is
designed to house specific pathogen free animals. Access to the instrument by the major/minor
users will be ensured through the administrative oversight of an Advisory Committee appointed
by the Chair of the R&D Committee. Administrative/technical service will be provided by Dr.
Sampen who has imaging analyses experience for more than a decade, and by a coordinator, Dr.
Natarajan Anbazhagan who has over 4 years of experience in directly operating the IVIS
SPECTRUMCT system. To ensure that the equipment is operated safely and appropriately
maintained with maximum efficiency, Drs. Sampen and Natarajan Anbazhagan will be further
trained by the Perkin Elmer Technical team with intensive training courses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application.
-
批准号:10366566
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
BLRD Research Career Scientist Award Application.
-
批准号:10513327
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Osteoarthritis and Knee Joint Pain
-
批准号:10427174
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
OSTEOARTHRITIS AND KNEE JOINT PAIN
-
批准号:8737435
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Osteoarthritis and Knee Joint Pain
-
批准号:10549317
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
OSTEOARTHRITIS AND KNEE JOINT PAIN
-
批准号:8967105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Osteoarthritis and Knee Joint Pain
-
批准号:10155426
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pain Mechanisms of Knee Joint Osteoarthritis
-
批准号:8502248
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2012
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pain Mechanisms of Knee Joint Osteoarthritis
-
批准号:8373029
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2012
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7847270
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2009
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7462439
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2006
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7645079
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2006
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7872840
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2006
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7142680
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2006
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
Pathological Role of bFGF in Human Adult Articular Cartilage
-
批准号:7280939
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2006
-
负责人:Hee-Jeong Im Sampen
-
依托单位:
海外基金